• Lamotrigine in BBB and Sodium Channel Research

  2026-08-31

  Lamotrigine supports a practical workflow that connects sodium-channel pharmacology, serotonin-pathway assays, and high-throughput blood-brain barrier screening. This guide shows how to control solubility, separate passive transport from efflux or lysosomal trapping, and extend findings cautiously into epilepsy and cardiac research.

• Ziprasidone Augmentation in Anxious Depression

  2026-08-30

  This post-hoc moderator analysis examined whether baseline anxious depression altered the response to ziprasidone augmentation of escitalopram in major depressive disorder. Ziprasidone augmentation improved depressive symptoms similarly in patients with and without anxious depression, while the apparent anxiety benefit was not clinically significant in the higher-anxiety subgroup.

• Angiotensin II: Practical Protocols for Vascular Models

  2026-08-29

  Angiotensin II (SKU A1042) provides a defined peptide stimulus for receptor-binding assays, vascular smooth muscle cell experiments, and controlled vascular remodeling models. It should be used as a research reagent under validated laboratory conditions, not for diagnostic, therapeutic, or clinical applications.

• Diminazene Aceturate and Angiotensin II in Cognitive Injury

  2026-08-28

  This 2026 FASEB Journal study identifies a CCN1–integrin αvβ6–TGF-β pathway that links Angiotensin II–induced hypertension to neuronal mitochondrial dysfunction and cognitive impairment. Its key mechanistic advance is showing that diminazene aceturate protects neurons partly by accelerating CCN1 mRNA degradation, providing a targetable post-transcriptional mechanism for hypertensive brain injury.

• α-Linolenic Acid: Applied Research Workflows

  2026-08-28

  Build reproducible ALA experiments for lipid metabolism, cardiovascular signaling, inflammation, and exploratory immune assays. This guide combines formulation controls, dose-ranging, analytical readouts, and troubleshooting while clearly separating established ALA applications from hypotheses inspired by arachidonic acid research.

• S1P/S1PR3 Drives Neuronal Apoptosis After ICH

  2026-08-28

  The reference study identifies S1PR3 as a mechanistic link between sphingosine-1-phosphate signaling, neuroinflammation, and neuronal apoptosis after acute intracerebral hemorrhage. Using mouse and HT22-cell models, the authors connect S1PR3 with CCL2, TNF-α, PI3K/AKT signaling, and cleaved caspase-3, while pharmacological S1PR3 blockade improves injury-associated outcomes.

• Angiotensin II: From Vasopressor to Translation

  2026-08-27

  Angiotensin II is more than a vasoactive peptide: it is a controllable perturbation for connecting GPCR signaling, oxidative stress, cardiac energy metabolism, and vascular remodeling. This thought-leadership guide uses recent miR-1268a/CD36 findings to help translational researchers design more informative cardiovascular models with APExBIO Angiotensin II, SKU A1042.

• NAT1–ENO1–Lactate Signaling in Colorectal Cancer

  2026-08-27

  A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator in colorectal cancer, showing that NAT1-dependent acetylation restrains ENO1, lactate production, and TRAF6-mediated PD-L1 stabilization. The work connects tumor glycolysis with checkpoint resistance and provides a preclinical rationale for testing lactate-pathway perturbation alongside PD-1 or PD-L1 blockade.

• Fosinopril Sodium: Assay Design Guide

  2026-08-26

  Fosinopril sodium is an ACE inhibitor whose prodrug activation, phosphinic acid chemistry, and mixed elimination pathways can materially shape experimental results. This assay-design guide translates foundational ACE pharmacology into practical strategies for hypertension research, cardiovascular disease models, and renal hemodynamics studies.

• Sex Differences in Angiotensin II Hypertension

  2026-08-26

  The reference study used telemetry in conscious, freely moving mice to show that chronic Angiotensin II infusion produced a much larger blood-pressure increase in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further implicated sex hormones, baroreflex resetting, and sympathetic activity as important determinants of this sexually divergent hypertension phenotype.

• SGC-CBP30: CREBBP/EP300 Bromodomain Workflows

  2026-08-25

  Use SGC-CBP30 to test whether CREBBP and EP300 bromodomain activity contributes to enhancer-driven transcription, rather than treating it as a nonspecific cytotoxic agent. This workflow connects biochemical potency with chromatin, transcriptional, viability, and invasion readouts relevant to epigenetics research and lung adenocarcinoma research.

• 7-Ethyl-10-hydroxycamptothecin Assay Guide

  2026-08-24

  This scenario-based guide explains how 7-Ethyl-10-hydroxycamptothecin, SKU N2133, can improve the interpretation and reproducibility of viability, proliferation, and cytotoxicity assays. It connects formulation, dose–time design, topoisomerase I inhibition, apoptosis, and FUBP1-related mechanisms to practical laboratory decisions.

• MK-8745: Aurora A Inhibitor Assay Guide

  2026-08-24

  A scenario-based laboratory guide to using MK-8745, Aurora A inhibitor, potent and selective (SKU A8807) in viability, cell-cycle, apoptosis, lymphoma, and xenograft research. It connects mechanism, model selection, formulation, controls, and vendor evaluation to improve interpretability and experimental consistency.

• Open-Platform DLP for 96-Well Hydrogel Printing

  2026-08-23

  The reference study presents a low-cost, open-platform digital light printer that fabricates two-dimensional hydrogels and locally activates photocaged DNA in multiwell formats. Its programmable exposure, wavelength flexibility, and compatibility with different vessels address important reproducibility and customization challenges in high-throughput biomaterials research.

• Resazurin Cell Viability Assay Kit Guide

  2026-08-22

  Learn how Resazurin Cell Viability Assay Kit, SKU K2234, can address low sensitivity, workflow complexity, and ambiguous metabolic readouts in cell viability and proliferation studies. This scenario-based guide covers assay principle, experimental compatibility, protocol optimization, data interpretation, and practical product selection.

449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page